Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents.
Wu Q, Tong J, Zhang B, Zhang D, Chen J, Lei Y, Lu Y, Wang Y, Li L, Shen Y, Xu J, Bailey LC, Bian J, Christakis DA, Fitzgerald ML, Hirabayashi K, Jhaveri R, Khaitan A, Lyu T, Rao S, Razzaghi H, Schwenk HT, Wang F, Gage Witvliet MI, Tchetgen Tchetgen EJ, Morris JS, Forrest CB, Chen Y.
Wu Q, et al. Among authors: morris js.
Ann Intern Med. 2024 Feb;177(2):165-176. doi: 10.7326/M23-1754. Epub 2024 Jan 9.
Ann Intern Med. 2024.
PMID: 38190711
Free article.
BACKGROUND: The efficacy of the BNT162b2 vaccine in pediatrics was assessed by randomized trials before the Omicron variant's emergence. The long-term durability of vaccine protection in this population during the Omicron period remains limited. ...
BACKGROUND: The efficacy of the BNT162b2 vaccine in pediatrics was assessed by randomized trials before the Omicron variant's emergence. The …